Evogene Ltd. (EVGN)
NASDAQ·Healthcare·Biotechnology
$0.78
+0.00%
Mkt Cap $6.67M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$3.50
Range $3.50 – $3.50
Implied Upside
+348.7%
Consensus $3.50 vs current $0.78
NASDAQ·Healthcare·Biotechnology
$0.78
+0.00%
Mkt Cap $6.67M
No recent rating data.
Price Target (2 analysts)
$3.50
Range $3.50 – $3.50
+348.7%
Consensus $3.50 vs current $0.78